<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Lessel I</submitter><funding>Austrian Science Fund FWF</funding><funding>NICHD NIH HHS</funding><funding>NHGRI NIH HHS</funding><funding>National Institute for Health Research (NIHR)</funding><funding>NINDS NIH HHS</funding><pagination>394-413</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11866971</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>112(2)</volume><pubmed_abstract>BCL11B is a Cys2-His2 zinc-finger (C2H2-ZnF) domain-containing, DNA-binding, transcription factor with established roles in the development of various organs and tissues, primarily the immune and nervous systems. BCL11B germline variants have been associated with a variety of developmental syndromes. However, genotype-phenotype correlations along with pathophysiologic mechanisms of selected variants mostly remain elusive. To dissect these, we performed genotype-phenotype correlations of 92 affected individuals harboring a pathogenic or likely pathogenic BCL11B variant, followed by immune phenotyping, analysis of chromatin immunoprecipitation DNA-sequencing data, dual-luciferase reporter assays, and molecular modeling. These integrative analyses enabled us to define three clinical subtypes </pubmed_abstract><journal>American journal of human genetics</journal><pubmed_title>DNA-binding affinity and specificity determine the phenotypic diversity in BCL11B-related disorders.</pubmed_title><pmcid>PMC11866971</pmcid><funding_grant_id>U01 NS134350</funding_grant_id><funding_grant_id>I 6657</funding_grant_id><funding_grant_id>U01 HG007672</funding_grant_id><funding_grant_id>NIHR203308</funding_grant_id><funding_grant_id>R01 HD109342</funding_grant_id><pubmed_authors>Tolosa E</pubmed_authors><pubmed_authors>Undiagnosed Diseases Network</pubmed_authors><pubmed_authors>Haack TB</pubmed_authors><pubmed_authors>Mancardi M</pubmed_authors><pubmed_authors>Elgizouli M</pubmed_authors><pubmed_authors>Iascone M</pubmed_authors><pubmed_authors>Nevay DL</pubmed_authors><pubmed_authors>Leppala J</pubmed_authors><pubmed_authors>Wieczorek D</pubmed_authors><pubmed_authors>Lyon GJ</pubmed_authors><pubmed_authors>Sebastian J</pubmed_authors><pubmed_authors>Chappe C</pubmed_authors><pubmed_authors>Lupski JR</pubmed_authors><pubmed_authors>Schrauwen I</pubmed_authors><pubmed_authors>Afenjar A</pubmed_authors><pubmed_authors>Averdunk L</pubmed_authors><pubmed_authors>Nigro V</pubmed_authors><pubmed_authors>Chandler KE</pubmed_authors><pubmed_authors>Isidor B</pubmed_authors><pubmed_authors>Hadonou M</pubmed_authors><pubmed_authors>Lessel D</pubmed_authors><pubmed_authors>Deb W</pubmed_authors><pubmed_authors>Harasink SM</pubmed_authors><pubmed_authors>Yuan B</pubmed_authors><pubmed_authors>Lessel I</pubmed_authors><pubmed_authors>Madan-Khetarpal S</pubmed_authors><pubmed_authors>Pappas J</pubmed_authors><pubmed_authors>Baresic A</pubmed_authors><pubmed_authors>Maeding N</pubmed_authors><pubmed_authors>Calle-Martin O</pubmed_authors><pubmed_authors>Kubisch C</pubmed_authors><pubmed_authors>Szakszon K</pubmed_authors><pubmed_authors>May J</pubmed_authors><pubmed_authors>Posey JE</pubmed_authors><pubmed_authors>Dubourg C</pubmed_authors><pubmed_authors>Kalinauskiene R</pubmed_authors><pubmed_authors>Kessler E</pubmed_authors><pubmed_authors>Leal SM</pubmed_authors><pubmed_authors>Josifova D</pubmed_authors><pubmed_authors>Dilena R</pubmed_authors><pubmed_authors>Jin JJ</pubmed_authors><pubmed_authors>Rabin R</pubmed_authors><pubmed_authors>Begtrup A</pubmed_authors><pubmed_authors>Rekab A</pubmed_authors><pubmed_authors>Platzer K</pubmed_authors><pubmed_authors>Luu SM</pubmed_authors><pubmed_authors>Banka S</pubmed_authors><pubmed_authors>Morel CF</pubmed_authors><pubmed_authors>Chong HJ</pubmed_authors><pubmed_authors>Tan QKG</pubmed_authors><pubmed_authors>Marchi E</pubmed_authors><pubmed_authors>Pastore MT</pubmed_authors><pubmed_authors>Menendez B</pubmed_authors><pubmed_authors>Capra V</pubmed_authors><pubmed_authors>Huning I</pubmed_authors><pubmed_authors>Hanker B</pubmed_authors><pubmed_authors>Brugger M</pubmed_authors><pubmed_authors>Cogne B</pubmed_authors><pubmed_authors>Kuechler A</pubmed_authors><pubmed_authors>Kamsteeg EJ</pubmed_authors><pubmed_authors>Mehta L</pubmed_authors><pubmed_authors>Keren B</pubmed_authors><pubmed_authors>Jorge AAL</pubmed_authors><pubmed_authors>Chinn IK</pubmed_authors><pubmed_authors>Gucsavas-Calikoglu M</pubmed_authors><pubmed_authors>Besnard T</pubmed_authors><pubmed_authors>Kolbel H</pubmed_authors><pubmed_authors>Sidlow R</pubmed_authors><pubmed_authors>Strunk D</pubmed_authors><pubmed_authors>Romano F</pubmed_authors><pubmed_authors>Wagner M</pubmed_authors><pubmed_authors>Fernandes E</pubmed_authors><pubmed_authors>Kozenko M</pubmed_authors><pubmed_authors>Robert L</pubmed_authors><pubmed_authors>Brager R</pubmed_authors><pubmed_authors>Goenka A</pubmed_authors><pubmed_authors>Sullivan J</pubmed_authors><pubmed_authors>Byrne S</pubmed_authors><pubmed_authors>Cardenas P</pubmed_authors><pubmed_authors>Cope H</pubmed_authors><pubmed_authors>Oegema R</pubmed_authors><pubmed_authors>Scala M</pubmed_authors><pubmed_authors>Fitzgerald KK</pubmed_authors><pubmed_authors>Rezende RC</pubmed_authors><pubmed_authors>Brick L</pubmed_authors><pubmed_authors>Brunet T</pubmed_authors><pubmed_authors>Gangi S</pubmed_authors><pubmed_authors>Poths K</pubmed_authors><pubmed_authors>Conboy E</pubmed_authors><pubmed_authors>Bedeschi MF</pubmed_authors><pubmed_authors>Perilla-Young Y</pubmed_authors><pubmed_authors>Courtin T</pubmed_authors><pubmed_authors>George-Abraham JK</pubmed_authors><pubmed_authors>Short J</pubmed_authors><pubmed_authors>Powell-Hamilton N</pubmed_authors><pubmed_authors>Jarvela I</pubmed_authors><pubmed_authors>Odent S</pubmed_authors></additional><is_claimable>false</is_claimable><name>DNA-binding affinity and specificity determine the phenotypic diversity in BCL11B-related disorders.</name><description>BCL11B is a Cys2-His2 zinc-finger (C2H2-ZnF) domain-containing, DNA-binding, transcription factor with established roles in the development of various organs and tissues, primarily the immune and nervous systems. BCL11B germline variants have been associated with a variety of developmental syndromes. However, genotype-phenotype correlations along with pathophysiologic mechanisms of selected variants mostly remain elusive. To dissect these, we performed genotype-phenotype correlations of 92 affected individuals harboring a pathogenic or likely pathogenic BCL11B variant, followed by immune phenotyping, analysis of chromatin immunoprecipitation DNA-sequencing data, dual-luciferase reporter assays, and molecular modeling. These integrative analyses enabled us to define three clinical subtypes </description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Feb</publication><modification>2026-06-01T08:52:39.974Z</modification><creation>2025-04-07T11:30:32.05Z</creation></dates><accession>S-EPMC11866971</accession><cross_references><pubmed>39798569</pubmed><doi>10.1016/j.ajhg.2024.12.012</doi></cross_references></HashMap>